This guide explains prescription drug monitoring programs (PDMPs), and how they can enhance clinical decision making. The guide also explains how PDMP improves patient safety, while helping to decrease prescription drug misuse and unintentional overdose deaths.

This guide explores barriers to accessing substance use disorder and mental health treatment services in rural communities, and the benefits of telehealth for these communities. It assists practitioners with implementing telehealth technologies as a means to increase access to services.

This resource provides information for clinicians who may encounter patients living with cognitive deficits related to chronic substance use disorder.

This brief highlights the relationship between substance use and suicide and gives an overview of the issue. It describes for state and tribal prevention professionals evidence-based programs that focus on substance use and suicide prevention.

This guide introduces professional care providers to borderline personality disorder (BPD). It covers signs and symptoms of BPD, with or without co-occurring substance use disorder. The guide also discusses the importance of monitoring clients for self-harm and suicide, and referrals to treatment.

This guide highlights the use of medication-assisted treatment (MAT) for opioid use disorder in drug courts. It reviews effective medications, including methadone, buprenorphine, and naltrexone. The guide also provides strategies to increase the use of MAT in drug court programs.